Talk:Postnatal - Growth Charts: Difference between revisions
No edit summary |
(→2010) |
||
| Line 51: | Line 51: | ||
==2010== | ==2010== | ||
===Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States=== | |||
MMWR Recomm Rep. 2010 Sep 10;59(RR-9):1-15. | |||
Grummer-Strawn LM, Reinold C, Krebs NF; Centers for Disease Control and Prevention (CDC). | |||
Source | |||
Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, USA. lxg8@cdc.gov | |||
Erratum in | |||
MMWR Recomm Rep. 2010 Sep 17;59(36):1184. | |||
Abstract | |||
In April 2006, the World Health Organization (WHO) released new international growth charts for children aged 0-59 months. Similar to the 2000 CDC growth charts, these charts describe weight for age, length (or stature) for age, weight for length (or stature), and body mass index for age. Whereas the WHO charts are growth standards, describing the growth of healthy children in optimal conditions, the CDC charts are a growth reference, describing how certain children grew in a particular place and time. However, in practice, clinicians use growth charts as standards rather than references. In 2006, CDC, the National Institutes of Health, and the American Academy of Pediatrics convened an expert panel to review scientific evidence and discuss the potential use of the new WHO growth charts in clinical settings in the United States. On the basis of input from this expert panel, CDC recommends that clinicians in the United States use the 2006 WHO international growth charts, rather than the CDC growth charts, for children aged <24 months (available at https://www.cdc.gov/growthcharts). The CDC growth charts should continue to be used for the assessment of growth in persons aged 2--19 years. The recommendation to use the 2006 WHO international growth charts for children aged <24 months is based on several considerations, including the recognition that breastfeeding is the recommended standard for infant feeding. In the WHO charts, the healthy breastfed infant is intended to be the standard against which all other infants are compared; 100% of the reference population of infants were breastfed for 12 months and were predominantly breastfed for at least 4 months. When using the WHO growth charts to screen for possible abnormal or unhealthy growth, use of the 2.3rd and 97.7th percentiles (or ±2 standard deviations) are recommended, rather than the 5th and 95th percentiles. Clinicians should be aware that fewer U.S. children will be identified as underweight using the WHO charts, slower growth among breastfed infants during ages 3-18 months is normal, and gaining weight more rapidly than is indicated on the WHO charts might signal early signs of overweight. | |||
PMID: 20829749 | |||
http://www.ncbi.nlm.nih.gov/pubmed/20829749 | |||
===Specialized Pediatric Growth Charts For Electronic Health Record Systems: the example of Down syndrome=== | ===Specialized Pediatric Growth Charts For Electronic Health Record Systems: the example of Down syndrome=== | ||
Revision as of 09:36, 6 July 2011
| About Discussion Pages |
|---|
Glossary Links
Cite this page: Hill, M.A. (2024, April 20) Embryology Postnatal - Growth Charts. Retrieved from https://embryology.med.unsw.edu.au/embryology/index.php/Talk:Postnatal_-_Growth_Charts |
2011
Growth standards of infants with Prader-Willi syndrome
Pediatrics. 2011 Apr;127(4):687-95. Epub 2011 Mar 14.
Butler MG, Sturich J, Lee J, Myers SE, Whitman BY, Gold JA, Kimonis V, Scheimann A, Terrazas N, Driscoll DJ. Source Department of Psychiatry, Kansas University Medical Center, 3901 Rainbow Blvd, MS 4015, Kansas City, KS 66160, USA. mbutler4@kumc.edu Abstract OBJECTIVE: To generate and report standardized growth curves for weight, length, head circumference, weight/length, and BMI for non-growth hormone-treated white infants (boys and girls) with Prader-Willi syndrome (PWS) between 0 and 36 months of age. The goal was to monitor growth and compare data with other infants with PWS.
METHODS: Anthropometric measures (N = 758) were obtained according to standard methods and analyzed from 186 non-growth hormone-treated white infants (108 boys and 78 girls) with PWS between 0 and 36 months of age. Standardized growth curves were developed and the 3rd, 10th, 25th, 50th, 75th, 90th, and 97th percentiles were calculated by using the LMS (refers to λ, μ, and σ) smoothing procedure method for weight, length, head circumference, weight/length, and BMI along with the normative 50th percentile using Centers for Disease Control and Prevention national growth data from 2003. The data were plotted for comparison purposes.
RESULTS: Five separate standardized growth curves (weight, length, head circumference, weight/length, and BMI) representing 7 percentile ranges were developed from 186 non-growth hormone-treated white male and female infants with PWS aged 0 to 36 months, and the normative 50th percentile was plotted on each standardized infant growth curve.
CONCLUSIONS: We encourage the use of these growth standards when examining infants with PWS and evaluating growth for comparison purposes, monitoring for growth patterns, nutritional assessment, and recording responses to growth hormone therapy, commonly used in infants and children with PWS.
PMID: 21402637 http://www.ncbi.nlm.nih.gov/pubmed/21402637
http://pediatrics.aappublications.org/content/127/4/687.long
Genetics of head circumference in infancy: A longitudinal study of Japanese twins
Am J Hum Biol. 2011 May 31. doi: 10.1002/ajhb.21190. [Epub ahead of print]
Silventoinen K, Karvonen M, Sugimoto M, Kaprio J, Dunkel L, Yokoyama Y. Source Population Research Unit, Department of Social Research, University of Helsinki, Helsinki, Finland; Department of Public Health, University of Helsinki, Helsinki, Finland. karri.silventoinen@helsinki.fi.
Abstract
OBJECTIVES: Previous studies have shown strong genetic influence to head circumference (HC), but still little is known on the development of genetic etiology of HC in infancy, especially in non-Caucasian populations. Thus, we decided to analyze the genetics of HC growth in Japanese infants. METHODS: Longitudinal measures of HC were available from birth to 13 months of age in 206 monozygotic and 156 dizygotic complete twin pairs. Genetic modeling for twin data was used. RESULTS: We found only little evidence for sex-specific differences in the genetics of HC and thus analyzed boys and girls together. After 5 months of age the heritability of HC was high, but before that age also a substantial common environmental component was present. Not only strong genetic persistence for HC was found but also a new genetic variation emerged. New environmental variation shared by co-twins affecting HC was found until 3 months of age, and this effect was further transmitted until 1 year of age. CONCLUSIONS: HC and its growth are strongly genetically regulated. Largely, the same genetic factors affect the variation of HC at different ages, and new genetic variation emerged during the first year of life. Knowledge on the genetic component in the variation of HC may help to design tools for defining abnormal growth of HC in population-based screenings for related disorders. Am. J. Hum. Biol., 2011. © 2011 Wiley-Liss, Inc. Copyright © 2011 Wiley-Liss, Inc.
PMID: 21630369 http://www.ncbi.nlm.nih.gov/pubmed/21630369
2010
Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States
MMWR Recomm Rep. 2010 Sep 10;59(RR-9):1-15.
Grummer-Strawn LM, Reinold C, Krebs NF; Centers for Disease Control and Prevention (CDC).
Source Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, USA. lxg8@cdc.gov Erratum in MMWR Recomm Rep. 2010 Sep 17;59(36):1184.
Abstract
In April 2006, the World Health Organization (WHO) released new international growth charts for children aged 0-59 months. Similar to the 2000 CDC growth charts, these charts describe weight for age, length (or stature) for age, weight for length (or stature), and body mass index for age. Whereas the WHO charts are growth standards, describing the growth of healthy children in optimal conditions, the CDC charts are a growth reference, describing how certain children grew in a particular place and time. However, in practice, clinicians use growth charts as standards rather than references. In 2006, CDC, the National Institutes of Health, and the American Academy of Pediatrics convened an expert panel to review scientific evidence and discuss the potential use of the new WHO growth charts in clinical settings in the United States. On the basis of input from this expert panel, CDC recommends that clinicians in the United States use the 2006 WHO international growth charts, rather than the CDC growth charts, for children aged <24 months (available at https://www.cdc.gov/growthcharts). The CDC growth charts should continue to be used for the assessment of growth in persons aged 2--19 years. The recommendation to use the 2006 WHO international growth charts for children aged <24 months is based on several considerations, including the recognition that breastfeeding is the recommended standard for infant feeding. In the WHO charts, the healthy breastfed infant is intended to be the standard against which all other infants are compared; 100% of the reference population of infants were breastfed for 12 months and were predominantly breastfed for at least 4 months. When using the WHO growth charts to screen for possible abnormal or unhealthy growth, use of the 2.3rd and 97.7th percentiles (or ±2 standard deviations) are recommended, rather than the 5th and 95th percentiles. Clinicians should be aware that fewer U.S. children will be identified as underweight using the WHO charts, slower growth among breastfed infants during ages 3-18 months is normal, and gaining weight more rapidly than is indicated on the WHO charts might signal early signs of overweight.
PMID: 20829749 http://www.ncbi.nlm.nih.gov/pubmed/20829749
Specialized Pediatric Growth Charts For Electronic Health Record Systems: the example of Down syndrome
AMIA Annu Symp Proc. 2010 Nov 13;2010:687-91.
Rosenbloom ST, McGregor TL, Chen Q, An AQ, Hsu S, Dupont WD. Source Departments of Biomedical Informatics.
Abstract
Electronic health record (EHR) systems serving pediatric populations typically incorporate growth charts to help healthcare providers monitor children's growth. Currently, easily implementable growth charts are not available for subpopulations having growth that differs from the population as a whole, such as children with Down syndrome. This manuscript describes an approach for generating subpopulation-specific growth charts meeting requirements for implementation into EHR systems, using as an example weights for children with Down syndrome. Gender-specific growth curves were generated from 2358 weight values obtained from 331 patients with Down syndrome from July 2001 until March 2005. The project generated printable curves and computable data tables formatted according to growth chart standards set forth by the Centers for Disease Control and Prevention to facilitate implementation into EHR systems. This approach will help developers implementing growth charts and provides actual data tables for monitoring growth in children with Down syndrome.
PMID: 21347066 http://www.ncbi.nlm.nih.gov/pubmed/21347066
